gip/glp-1 receptor agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research π§π΅π² ππ³π³π²π°π πΌπ³ πππ£-π π₯π²π°π²π½ππΌπΏ
Description
Nationwide retrospective studies utilizing register data from Sweden and Denmark (20132021) and the UK CPRD (20072020) have revealed consistent findings, indicating that GLP-1 RAs are not associated with an elevated risk of suicidality relative to DPP-4 or SGLT-2 inhibitors [77,78]
(35) Proposed benefits include anti-inflammatory effects, modulation of bone metabolism, and preservation of skeletal muscle during weight loss
Technological innovation: The pressure of GLP-1 demand is driving tech innovation

But eager for business, they are now formulating new variations of the drugs adding new ingredients, using different forms of the hormones or creating new delivery methods (such as sublingual drops or tablets that dissolve under your tongue) so they can claim they are different products

Abstract Glucagon-like petide-1 (GLP-1) potentiates insulin and suppresses glucagon secretion from the pancreas in response to the ingestion of nutrients
GLP-2 A hormone consisting of 33 amino acids, GLP-2 is encoded by a section of the proglucagon gene that is located closely to the sequence that encodes GLP-1
